16:14 EST Quince Therapeutics (QNCX) files $200M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNCX:
- Quince Therapeutics initiated with a Buy at Brookline
- Quince Therapeutics management to meet with Maxim Group
- Quince Therapeutics presents data from prior Phase 3 ATTeST clinical trial
- Quince Therapeutics presents safety data from ATTeST trial at CNS meeting
- Quince Therapeutics initiated with a Buy at Maxim